Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 259

    1.

    Long-term outcomes of scleroderma renal crisis.

    Steen VD, Medsger TA Jr.

    Ann Intern Med. 2000 Oct 17;133(8):600-3.PMID: 11033587 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.

    Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr.

    Ann Intern Med. 1990 Sep 1;113(5):352-7.PMID: 2382917 [PubMed - indexed for MEDLINE]Related articles

    3.

    Scleroderma renal crisis: patient characteristics and long-term outcomes.

    Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, Burns A, Denton CP.

    QJM. 2007 Aug;100(8):485-94. Epub 2007 Jun 29.PMID: 17601770 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment.

    Walker JG, Ahern MJ, Smith MD, Coleman M, Pile K, Rischmueller M, Cleland L, Roberts-Thomson PJ.

    Intern Med J. 2003 May-Jun;33(5-6):216-20.PMID: 12752889 [PubMed - indexed for MEDLINE]Related articles

    5.

    Diagnosis, management and prevention of scleroderma renal disease.

    Penn H, Denton CP.

    Curr Opin Rheumatol. 2008 Nov;20(6):692-6. Review.PMID: 18946330 [PubMed - indexed for MEDLINE]Related articles

    6.

    Scleroderma renal crisis is still a life-threatening syndrome.

    Stratta P, Besso L, Ferrero S, Canavese C, Hollo S, Ottone S, Sandri L, Thea A, Mazzucco G.

    Ren Fail. 1996 Jul;18(4):567-74.PMID: 8875681 [PubMed - indexed for MEDLINE]Related articles

    7.

    Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.

    Teixeira L, Mouthon L, Mahr A, Berezné A, Agard C, Mehrenberger M, Noël LH, Trolliet P, Frances C, Cabane J, Guillevin L; Group Français de Recherche sur le Sclérodermie (GFRS).

    Ann Rheum Dis. 2008 Jan;67(1):110-6. Epub 2007 Jun 8.PMID: 17557890 [PubMed - indexed for MEDLINE]Related articles

    8.

    Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.

    DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WK, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA Jr, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ.

    Arthritis Rheum. 2002 Nov;46(11):2983-9.PMID: 12428241 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Factors predicting development of renal involvement in progressive systemic sclerosis.

    Steen VD, Medsger TA Jr, Osial TA Jr, Ziegler GL, Shapiro AP, Rodnan GP.

    Am J Med. 1984 May;76(5):779-86.PMID: 6372452 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients.

    Kolesnyk I, Dekker FW, Noordzij M, le Cessie S, Struijk DG, Krediet RT.

    Perit Dial Int. 2007 Jul-Aug;27(4):446-53.PMID: 17602154 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [Renal crisis in scleroderma]

    Fagel WJ, van Es LA.

    Ned Tijdschr Geneeskd. 1992 Dec 26;136(52):2588-90. Dutch. PMID: 1480244 [PubMed - indexed for MEDLINE]Related articles

    13.

    Bier's white spots associated with scleroderma renal crisis.

    Peyrot I, Boulinguez S, Sparsa A, Le Meur Y, Bonnetblanc JM, Bedane C.

    Clin Exp Dermatol. 2007 Mar;32(2):165-7. Epub 2006 Nov 27.PMID: 17137483 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases.

    Traub YM, Shapiro AP, Rodnan GP, Medsger TA, McDonald RH Jr, Steen VD, Osial TA Jr, Tolchin SF.

    Medicine (Baltimore). 1983 Nov;62(6):335-52.PMID: 6355755 [PubMed - indexed for MEDLINE]Related articles

    15.

    Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients.

    Whitman HH 3rd, Case DB, Laragh JH, Christian CL, Botstein G, Maricq H, Leroy EC.

    Arthritis Rheum. 1982 Mar;25(3):241-8.PMID: 6279117 [PubMed - indexed for MEDLINE]Related articles

    16.

    ACE inhibitors and survival of hemodialysis patients.

    Efrati S, Zaidenstein R, Dishy V, Beberashvili I, Sharist M, Averbukh Z, Golik A, Weissgarten J.

    Am J Kidney Dis. 2002 Nov;40(5):1023-9.PMID: 12407648 [PubMed - indexed for MEDLINE]Related articles

    17.

    Renal complications and scleroderma renal crisis.

    Denton CP, Lapadula G, Mouthon L, Müller-Ladner U.

    Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii32-5. Review.PMID: 19487221 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study.

    Li PK, Chow KM, Wong TY, Leung CB, Szeto CC.

    Ann Intern Med. 2003 Jul 15;139(2):105-12.PMID: 12859160 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition.

    Losito A, Errico R, Santirosi P, Lupattelli T, Scalera GB, Lupattelli L.

    Nephrol Dial Transplant. 2005 Aug;20(8):1604-9. Epub 2005 May 3.PMID: 15870215 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature.

    Akoglu H, Atilgan GK, Ozturk R, Yenigun EC, Gonul II, Odabas AR.

    Rheumatol Int. 2009 Aug;29(10):1223-9. Epub 2008 Dec 2. Review.PMID: 19048256 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data